Coherent (COHR) Form 4: Director Receives 2,272 Restricted Stock Units
Rhea-AI Filing Summary
Patrick Elizabeth, a director of Coherent Corp. (COHR), received a grant of 2,272 restricted stock units (RSUs) recorded as a non‑derivative acquisition on 08/28/2025. The RSUs were awarded at no cash price and are scheduled to vest on 08/28/2026. After this grant, the reporting person’s beneficial ownership is reported as 5,103 shares.
The filing indicates the award is an equity compensation grant that will convert to common shares upon vesting; the filing lists a power of attorney exhibit and is signed by an attorney‑in‑fact on behalf of the reporting person.
Positive
- Director alignment: RSU award ties the director's compensation to share performance and retention through a one‑year vesting schedule.
- Clear disclosure: Form 4 reports the grant size (2,272 RSUs) and resulting beneficial ownership (5,103 shares), providing transparency to investors.
Negative
- Potential dilution: If the RSUs vest, they will increase outstanding shares, modestly diluting existing shareholders.
- No performance conditions disclosed: The grant is a time‑based RSU with no disclosed performance metrics to link to company results.
Insights
TL;DR: Routine director RSU award aligns long‑term incentives; vesting in one year suggests retention focus rather than immediate performance pay.
The 2,272 RSU grant appears typical for non‑executive board compensation and vests after one year, which supports alignment with shareholder interests by deferring delivery of shares. Because the award was granted at $0, it is a standard equity grant rather than a purchase; the reported post‑transaction ownership of 5,103 shares shows modest incremental dilution. No irregular governance flags or related‑party transactions are disclosed in the form.
TL;DR: The transaction is non‑material to equity capital structure but increases insider holdings slightly upon vesting.
The disclosure records an RSU issuance of 2,272 units that will convert into common stock when they vest. The grant price is listed as $0, indicating a compensatory award. This transaction does not present a cash inflow or change to reported debt; its primary effect is potential share count increase if all units vest. No derivatives or option exercises are reported.